Skip to main content
Clinical Trials/CTRI/2022/01/039559
CTRI/2022/01/039559CompletedNot Applicable

The Clinico-Epidemiological Profile of Dermatophytosis in Patients Attending Homoeopathic Consultation at Tertiary Care Centre of Bhopal: A Cross Sectional Study

All India Institute of Medical Sciences1 site in 1 country100 target enrollmentStarted: January 24, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
1. Intensity of Pruritus on a 0-10 Numeric Rating Scale (NRS)

Study Overview

Brief Summary

Homoeopathy as an alternative therapy offers treatment for the various clinical subtypes of dermatophytosis. Many patients regularly seek homoeopathic consultations in the outpatient department (OPD) as evidenced by various case reports suggesting the therapeutic utility of homoeopathy. But the availability of scanty data on the prevalence and some associated 18 epidemiological factors of dermatophytosis in patients attending homoeopathy OPD for the alternative treatment prompted to take up the present study.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
0.00 Year(s) to 89.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All patients diagnosed with dermatophytosis visited the homoeopathy outpatient department.
  • Age limit and Sex bias will not be used and patients of any age group and both sexes will be included.

Exclusion Criteria

  • Patients on antifungal drugs during past 2 months.

Outcomes

Primary Outcomes

1. Intensity of Pruritus on a 0-10 Numeric Rating Scale (NRS)

Time Frame: At Baseline, 4th week, 8th week and 12th week.

2. Dermatology Life Quality Index (DLQI)

Time Frame: At Baseline, 4th week, 8th week and 12th week.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials